Transgenic Rabbits That Overexpress the Neonatal Fc Receptor (FcRn) Generate Higher Quantities and Improved Qualities of Anti-Thymocyte Globulin (ATG)

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Baranyi, Mária ^a   Cervenak, Judit ^a   Bender, Balázs ^a   Kacskovics, Imre ^a  

^a ImmunoGenes Kft ^*  (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; FC RECEPTOR; IMMUNOGLOBULIN G; OVALBUMIN; THYMOCYTE ANTIBODY; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RABBIT; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GEL CHROMATOGRAPHY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSGENIC ANIMAL;

ALPHA 1-ANTITRYPSIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTILYMPHOCYTE SERUM; B-LYMPHOCYTES; CHROMATOGRAPHY, AGAROSE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN; RABBITS; RECEPTORS, FC;

EID: 84886011191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076839     Document Type: Article

References (47)

1. Mohty M, (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 21: 1387-1394.
2. Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, et al. (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93: 2191-2195.
3. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, et al. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339: 1186-1193.
4. Ringden O, Remberger M, Carlens S, Hagglund H, Mattsson J, et al. (1998) Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation 66: 620-625.
5. Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, et al. (1985) Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 40: 162-166.
6. Storb R, Gluckman E, Thomas ED, Buckner CD, Clift RA, et al. (1974) Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood 44: 56-75.
7. Cosimi AB, editor (1988) Antilymphocyte globulins and monoclonal antibodies. Saunders, Philadelphia, PA. 343 p.
8. Bonnefoy-Berard N, Genestier L, Flacher M, Rouault JP, Lizard G, et al. (1994) Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines. Blood 83: 1051-1059.
9. Ayuk FA, Fang L, Fehse B, Zander AR, Kroger N, (2005) Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells. Exp Hematol 33: 1531-1536.
10. Bonnefoy-Berard N, Revillard JP, (1996) Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 15: 435-442.
11. Timm MM, Kimlinger TK, Haug JL, Kline MP, Greipp PR, et al. (2006) Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma. Leukemia 20: 1863-1869.
12. Zand MS, Vo T, Pellegrin T, Felgar R, Liesveld JL, et al. (2006) Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood 107: 2895-2903.
13. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N, (2006) A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 17: 2844-2853.
14. Theurich S, Reisberg A, Christopeit M, von Bergwelt-Baildon M, Weber T, et al. (2010) CD4+ CD25highFoxP3+ Regulatory T Cells Are Increased And Functionally Active After Antithymocyte Globulin Infusion And Allogeneic Stem Cell Transplantation In Humans- A Novel In Vivo Mechanism Of Action. Biology of Blood and Marrow Transplantation 16: S220.
15. Ayuk F, Zander A, Kroger N, (2009) Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma. Annals of hematology 88: 401-404.
16. Lonberg N, (2005) Human antibodies from transgenic animals. Nat Biotechnol 23: 1117-1125.
17. Catunda Lemos AP, Cervenak J, Bender B, Hoffmann OI, Baranyi M, et al. (2012) Characterization of the Rabbit Neonatal Fc Receptor (FcRn) and Analyzing the Immunophenotype of the Transgenic Rabbits That Overexpresses FcRn. PLoS One 7: e28869.
18. Levey RH, Medawar PB, (1966) Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A 56: 1130-1137.
19. Jooste SV, Lance EM, Levey RH, Medawar PB, Ruszkiewicz M, et al. (1968) Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology 15: 697-705.
20. Preville X, Nicolas L, Flacher M, Revillard JP, (2000) A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG). Journal of Immunological Methods 245: 45-54.
21. Cervenak J, Bender B, Schneider Z, Magna M, Carstea BV, et al. (2011) Neonatal FcR Overexpression Boosts Humoral Immune Response in Transgenic Mice. J Immunol 186: 959-968.
22. Schneider Z, Cervenak J, Baranyi M, Papp K, Prechl J, et al. (2011) Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity. Immunology Letters 137: 62-69.
23. Beiras-Fernandez A, Thein E, Hammer C, (2003) Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Exp Clin Transplant 1: 79-84.
24. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, et al. (2005) Protective conditioning for acute graft-versus-host disease. N Engl J Med 353: 1321-1331.
25. Bourdage JS, Hamlin DM, (1995) Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 59: 1194-1200.
26. Bonnefoy-Berard N, Vincent C, Revillard JP, (1991) Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51: 669-673.
27. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, et al. (1998) Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91: 2360-2368.
28. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, et al. (2003) Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 75: 657-662.
29. Zand MS, Vo T, Huggins J, Felgar R, Liesveld J, et al. (2005) Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 79: 1507-1515.
30. Brennan DC, (2003) Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantation. Transplantation 75: 577-578.
31. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N, (2006) A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. Journal of the American Society of Nephrology: JASN 17: 2844-2853.
32. Roopenian DC, Akilesh S, (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7: 715-725.
33. Vidarsson G, Stemerding AM, Stapleton NM, Spliethoff SE, Janssen H, et al. (2006) FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 108: 3573-3579.
34. Qiao SW, Kobayashi K, Johansen FE, Sollid LM, Andersen JT, et al. (2008) Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A 105: 9337-9342.
35. Mi W, Wanjie S, Lo ST, Gan Z, Pickl-Herk B, et al. (2008) Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol 181: 7550-7561.
36. Liu X, Lu L, Yang Z, Palaniyandi S, Zeng R, et al. (2011) The Neonatal FcR-Mediated Presentation of Immune-Complexed Antigen Is Associated with Endosomal and Phagosomal pH and Antigen Stability in Macrophages and Dendritic Cells. J Immunol 186: 4674-4686.
37. Baker K, Qiao SW, Kuo TT, Aveson VG, Platzer B, et al. (2011) Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 108: 9927-9932.
38. Lu W, Zhao Z, Zhao Y, Yu S, Zhao Y, et al. (2007) Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice. Immunology 122: 401-408.
39. Petkova SB, Akilesh S, Sproule TJ, Christianson GJ, Al Khabbaz H, et al. (2006) Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18: 1759-1769.
40. Bender B, Bodrogi L, Mayer B, Schneider Z, Zhao Y, et al. (2007) Position independent and copy-number-related expression of the bovine neonatal Fc receptor alpha-chain in transgenic mice carrying a 102 kb BAC genomic fragment. Transgenic Res 16: 613-627.
41. Vegh A, Farkas A, Kovesdi D, Papp K, Cervenak J, et al. (2012) FcRn Overexpression in Transgenic Mice Results in Augmented APC Activity and Robust Immune Response with Increased Diversity of Induced Antibodies. PLoS One 7: e36286.
42. Vegh A, Cervenak J, Jankovics I, Kacskovics I, (2011) FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen. mAbs 3: 173-180.
43. Groves DJ, Morris BA, (2000) Veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas. Hybridoma 19: 201-214.
44. Popkov M, Mage RG, Alexander CB, Thundivalappil S, Barbas CF 3rd, et al. (2003) Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. Journal of molecular biology 325: 325-335.
45. Flisikowska T, Thorey IS, Offner S, Ros F, Lifke V, et al. (2011) Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PloS one 6: e21045.
46. Brambell FWR (1970) The Transmission of Passive Immunity from Mother to Young; Neuberger A, Tatum EL, editors. Amsterdam: North-Holland Publishing Company.
47. Spiegelberg HL, Weigle WO, (1965) The Catabolism of Homologous and Heterologous 7 s Gamma Globulin Fragments. J Exp Med 121: 323-338.